Project Expected benefits

CSFV_goDIVA

The expected outputs of the present FP7-project:

  • 1. Scientific:
    • a. Better understanding of CSF epidemiology, including pathogenesis, transmission and reservoir
    • b. Evaluation of the third generation of live CSF marker vaccines
    • c. Development and validation of accompanying discriminatory tests detecting antibody response as well as the differentiating of viral antigens
    • d. Scenario-analysis and cost-effort evaluation of control protocols in domestic pigs
    • e. Design of specific sampling protocols
    • f. Better understanding of the mucosal immune response after oral vaccine delivery
    • g. Insight in the potential use of antivirals as a possible control strategy
    • h. Development and evaluation of new or adapted techniques usable under low-tech and on-site environments
  • 2. Technical and policy support:
    • a. A safe and efficient live marker vaccine and accompanying test for use in domestic pigs, wild boar and back yard pigs
    • b. Tools for easier selection of suspected animals
    • c. First generation of antivirals and a support strategy towards registration
    • d. Epidemiological tools to estimate the risks, the benefits and the costs of possible interventions
    • e. Sampling protocols applicable for specific emergency situation
    • f. Graduation of cost efficiency, feasibility and success potential of available control strategies (existing and alternative) for the emergency situation in domestic pigs
    • g. Improved understanding of CSF perpetuation and of control options in back yard pig
    • h. Improved understanding of CSF transmission and persistence in wild boar
    • i. Improved management options of CSF in wild boar by the development of a new marker vaccine, easy oral application pathways and adequate baiting strategies

Links